chronic neck pain. Cervicalgia
Conditions
Interventions
Intervention 1: Intervention group: Patients who enter the group receiving mesotherapy treatment will be treated with the following method: The materials used for mesotherapy will include sterile disp
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) Age range: Patients between 18 and 60 years of age are eligible to participate. ,2) Documented diagnosis of chronic neck pain: Patients must have a documented diagnosis of chronic neck pain based on clinical physical examination findings, with the presence of at least one trigger point (a hyperexcitable focus in a stretched band of skeletal muscle that is painful when compressed and can report a characteristic pattern of pain when stimulated (usually by pressure, tapping, or pricking) in the neck region (in the upper trapezius and paraspinal cervical muscles) for at least 12 weeks, as confirmed by a qualified physical medicine and rehabilitation specialist. 3) Normal neurological examination: Patients must have a normal neurological examination that indicates the absence of neurological abnormalities. 4) The patient's VAS score is greater than or equal to 3 5) The duration of symptoms must be at least 12 weeks.
Exclusion criteria
Exclusion criteria: 1) Acute neck pain (symptoms present for less than 12 weeks) 2) History or history of lidocaine allergy 3) Cervical vertebral fracture, spondylolisthesis, spinal stenosis, cervical radiculopathy (based on history and clinical examination) 4) Rheumatological, oncological, neurological, infectious disease, severe systemic autoimmune disease 5) History of neck surgery 6) Severe cognitive impairment 7) Pregnancy 8) Patients who have undergone any therapeutic intervention for the management of chronic neck pain in the past two months before the study interventions, such as physiotherapy or trigger point injections. 9) Patients with diseases such as acute radiculopathy (nerve root disorders), coagulation (bleeding disorders), or those who were using anticoagulant drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of chronic neck pain. Timepoint: Before, one month and four months after the completion of the intervention. Method of measurement: Visual Analogue Scale and neck disability index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Average pain intensity. Timepoint: Before, one month and four months after the completion of the intervention. Method of measurement: Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtieh Mohsenpour
Esfahan University of Medical Sciences
Outcome results
None listed